Antimicrobial resistance (AMR) presents a formidable global health challenge, jeopardizing the efficacy of current antibiotics and posing a substantial threat to public health. The escalating prevalence of AMR demands innovative solutions. However, the traditional drug discovery process for combating AMR is marked by significant costs, prolonged timelines, frequent inefficacies, and numerous developmental ...